Inventor
John A. Kink
Inventor
Madison, WI, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
C07KPeptides15%
C12NMicroorganisms or enzymes10%
C12YEnzymes8%
Y02ATechnologies for adaptation to climate change8%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
A61NElectrotherapy2%
A61QSpecific use of cosmetics or similar toiletry preparations1%
B82YSpecific uses or applications of nanostructures1%
PatentTitleYear
9,839,638'Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy'20179,579,365'Therapeutic ribonucleases'20179,192,656'Methods and compositions for the treatment of cancer'20159,006,407'Therapeutic ribonucleases'20158,840,882'Modified ribonucleases'20148,697,062'Compositions and methods for ribonuclease-based therapeutics'20148,628,768'Therapeutic ribonucleases'20148,461,136'Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy'20138,298,801'Methods and compositions for the treatment of cancer'20128,216,567'Therapeutic ribonucleases'20128,029,782'Therapeutic ribonucleases'20117,531,562'Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy'20097,494,652'Treatment of sepsis'20097,261,891'Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease'20077,045,550'Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy'20066,663,864'Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease'20036,613,329'Vaccine and antitoxin for treatment and prevention of C. difficile disease'20036,573,003'Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease'20036,395,273'Prevention and treatment of inflammatory bowel disease'20026,365,158'Methods for producing neutralizing antitoxin to C. difficile toxin B'20026,346,247'Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies'20026,290,960'Vaccine and antitoxin for the treatment of C. difficile disease'20016,214,343'Prevention and treatment of necrotizing enterocolitis'20015,814,477'Recombinant clostridial toxin protein'19985,762,934'Clostridium difficile toxin disease therapy'19985,747,240'Epitope mapping of the c33 region of HCV'19985,736,139'Treatment of Clostridium difficile induced disease'19985,601,823'Avian antitoxins to clostridium difficle toxin A'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997–2001Patents assigned to OPHIDIAN PHARM INC (6)· patent assignee history
1997–2017Based in Madison, WI, US· patent location history
1998Based in Lake Villa, IL, US· patent location history
2002–2009Patents assigned to PROMEGA CORP (8)· patent assignee history
2011–2017Patents assigned to QUINTESSENCE BIOSCIENCES INC (9)· patent assignee history
2012–2015Patents assigned to KINK JOHN A (5)· patent assignee history
2012–2015Patents assigned to STRONG LAURA E (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| QUINTESSENCE BIOSCIENCES INC | 9 | 2011–2017 |
| PROMEGA CORP | 8 | 2002–2009 |
| OPHIDIAN PHARM INC | 6 | 1997–2001 |
| KINK JOHN Aself | 5 | 2012–2015 |
| STRONG LAURA E | 4 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Madison, WI, US | 27 | 1997–2017 |
| Lake Villa, Illinois, US | 1 | 1998 |